Friday, 03 July 2020 15:02

The ISN-ACT Committee Releases Statement to Encourage the Inclusion of Kidney Patients in Research Activities.

The International Society of Nephrology urges all investigators and industry partners to include people with kidney diseases in research activities related to COVID-19.

The ISN-ACT (Advancing Clinical Trials) Committee has released a statement on the urgent need to include patients with kidney diseases in clinical trials related to COVID-19.

Despite preliminary studies demonstrating the increased risk for people with kidney diseases to develop severe COVID-19 symptoms or to die from COVID-19, kidney patients are frequently excluded from COVID-19-related clinical trials. Effective therapies are needed to prevent and treat COVID-19 in all patients, including those with kidney diseases, and to reduce the current burden to healthcare systems.

Read the full statement here

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

               

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact